A phase I/II study of paclitaxel (Taxol®) and concurrent radiotherapy in advanced nonsmall cell lung cancer
- 1 December 1997
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 39 (5) , 1107-1111
- https://doi.org/10.1016/s0360-3016(97)00548-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer.Journal of Clinical Oncology, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancerAnnals of Oncology, 1995
- Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Taxol: A novel radiation sensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Sequelae of Radical Radiotherapy of Carcinoma of the LungRadiology, 1964